Market capitalization | JPY2.19t |
Enterprise Value | JPY1.57t |
P/E (TTM) P/E ratio | 12.56 |
EV/FCF (TTM) EV/FCF | 10.95 |
EV/Sales (TTM) EV/Sales | 3.58 |
P/S ratio (TTM) P/S ratio | 5.00 |
P/B ratio (TTM) P/B ratio | 1.57 |
Dividend yield | 2.62% |
Last dividend (FY26) | JPY66.00 |
As a Free StocksGuide user, you can view scores for all 6,842 stocks worldwide.
12 Analysts have issued a Shionogi & forecast:
12 Analysts have issued a Shionogi & forecast:
Mar '25 |
+/-
%
|
||
Revenue | 438,268 438,268 |
1%
1%
|
|
Gross Profit | 374,442 374,442 |
1%
1%
|
|
EBITDA | 160,781 160,781 |
2%
2%
|
EBIT (Operating Income) EBIT | 156,603 156,603 |
2%
2%
|
Net Profit | 170,435 170,435 |
5%
5%
|
In millions JPY.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Shionogi & Co., Ltd. engages in the research, development, supply, manufacture, and sale of pharmaceutical products. Its products include prescription drugs, over-the-counter drugs, diagnostic regents, medical devices and others. The company was founded by Gisaburo Shiono on March 17, 1878 and is headquartered in Osaka, Japan.
Head office | Japan |
CEO | Isao Teshirogi |
Employees | 4,959 |
Founded | 1878 |
Website | www.shionogi.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.